Dexcom Q3 2026 Results: Net Income $275M, Down 3.1% YoY
DexCom reported revenue of $1.34 billion for the third quarter of 2026, representing growth over the $1.21 billion reported in the prior year period. Net income for the nine months ended September 30, 2026, increased to $723.7 million compared to $569.0 million in 2025, driven by higher gross profits and operating income.
- Key figure
- Net income $275M · -3.1% YoY